4//SEC Filing
Toselli Richard M. 4
Accession 0001179110-20-012218
CIK 0001292519other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:14 PM ET
Size
5.7 KB
Accession
0001179110-20-012218
Insider Transaction Report
Form 4
Toselli Richard M.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2020-12-21$0.60/sh−16$10→ 6,238 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 50 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying the unvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.
- [F2]The Form 4 filed by the reporting person with the SEC on March 12, 2020 inadvertently reported 6069 shares as beneficially owned following the transaction instead of 6,269 shares. The total shares reported in Column 5 reflects the corrected number of shares beneficially owned by the Reporting Person following the transactions reported on this Form 4.
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeother
Related Parties
1- filerCIK 0001710549
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:14 PM ET
- Size
- 5.7 KB